Welcome to LookChem.com Sign In|Join Free
  • or
ethyl 3-amino-1-phenyl-1H-inden-2-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

245124-53-2

Post Buying Request

245124-53-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

245124-53-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 245124-53-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,5,1,2 and 4 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 245124-53:
(8*2)+(7*4)+(6*5)+(5*1)+(4*2)+(3*4)+(2*5)+(1*3)=112
112 % 10 = 2
So 245124-53-2 is a valid CAS Registry Number.

245124-53-2Downstream Products

245124-53-2Relevant academic research and scientific papers

Synthesis of a novel class of non-peptide NK-2 receptor ligand, derived from 1-phenyl-3-pyrrol-1-ylindan-2-carboxamides

Guillon, Jean,Dallemagne, Patrick,Leger, Jean-Michel,Sopkova, Jana,Bovy, Philippe R,Jarry, Christian,Rault, Sylvain

, p. 1043 - 1050 (2002)

A series of trans,trans-1-phenyl-3-pyrrol-1-ylindan-2-carboxamide derivatives has been synthesized in eight steps starting from cinnamic acid or 3,3-diphenylpropionic acid. The trans,trans configuration of these carboxamides has been established by X-ray analysis and by NOE experiments in NMR. These new compounds were evaluated for their potential NK-1, NK-2 and NK-3 receptors binding affinity. The N,N-disubstituted carboxamides bound selectively on NK-2 receptors. Copyright

First synthesis of 1-phenyl-3-pyrrol-1-ylindan-2-carboxylic acid, a new scaffold of potential non-peptide endothelin receptor antagonists

Guillon, Jean,Dallemagne, Patrick,Stiebing, Silvia,Bovy, Philippe R.,Rault, Sylvain

, p. 1263 - 1264 (2007/10/03)

The first synthesis of trans, trans-1-phenyl-3-pyrrol-1-ylindan-2- carboxylic acid, a key-intermediate in the access to new potential non- peptide endothelin receptor antagonists, is reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 245124-53-2